Cargando…

Clinical evaluation of endotoxin hemoadsorption therapy (PMX-DHP) for hypercytokinemia caused by septic multiple organ failure

Detalles Bibliográficos
Autores principales:	Ikeda, T, Ikeda, K, Nagura, M, Taniuchi, H, Matsushita, M, Kuroki, Y, Suzuki, K, Matsuno, N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099735/ http://dx.doi.org/10.1186/cc2615

Ejemplares similares

Is it true that PMX-DHP can improve lung oxygenation?
por: Ikeda, T, et al.
Publicado: (2003)

The role of plasminogen activator inhibitor 1 measurement with endotoxin adsorption therapy (PMX-DHP) for postoperative septic shock patients
por: Ikeda, T, et al.
Publicado: (2007)

Effect of PMX-DHP according to differences in infection site
por: Ikeda, T, et al.
Publicado: (2001)

Changes in procalcitonin in septic shock patients treated with endotoxin adsorption therapy
por: Ikeda, T, et al.
Publicado: (2005)

Observational study for direct hemoperfusion therapy with polymyxin-B immobilized fibers (PMX-DHP) in patients with septic shock in Japan: PMX-DHP study group
por: Kase, Y, et al.
Publicado: (2009)

Efficacy of the endotoxin absorption method (PMX) in patients with septic shock associated with intraperitoneal infections
por: Ikeda, T, et al.
Publicado: (2000)

A retrospective investigation of the pmx-dhp's efficacy in 88 severe sepsis cases
por: Tanaka, M, et al.
Publicado: (2015)

Alteco endotoxin hemoadsorption in Gram-negative septic shock patients
por: Shum, HP, et al.
Publicado: (2013)

Tocilizumab and PMX-DHP have efficacy for severe COVID-19 pneumonia
por: Shinomiya, Shohei, et al.
Publicado: (2021)

PMX-DHP Therapy for Dyspnea and Deoxygenation in Severe COVID-19 Pneumonia: A Case Series
por: Kuwana, Tsukasa, et al.
Publicado: (2021)

Alteco endotoxin hemoadsorption in Gram-negative septic shock patients
por: Shum, Hoi Ping, et al.
Publicado: (2014)

New sepsis-related marker: endotoxin activity assay
por: Ikeda, T, et al.
Publicado: (2010)

Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock
por: Shoji, Hisataka, et al.
Publicado: (2021)

Physiological response to superantigen-adsorbing hemoperfusion in toxin-concentration-controlled septic swine
por: Ikeda, T, et al.
Publicado: (2006)

Cytokine Hemoadsorption as Rescue Therapy for Critically Ill Patients With SARS-CoV-2 Pneumonia With Severe Respiratory Failure and Hypercytokinemia
por: Ruiz-Rodríguez, Juan Carlos, et al.
Publicado: (2022)

Continuous hemodiafiltration for hypercytokinemia in tumor lysis syndrome
por: Nakamura, M, et al.
Publicado: (2005)

The Characteristics of Patients with Severe COVID-19 Pneumonia Treated with Direct Hemoperfusion Using Polymyxin B-Immobilized Fiber Column (PMX-DHP)
por: Kuwana, Tsukasa, et al.
Publicado: (2022)

Correlation between changes in mediators and number of dysfunctional organs in sepsis-associated multiple organ dysfunction syndrome (MODS)
por: Taniuchi, H, et al.
Publicado: (2003)

Effect of continuous hemodiafiltration (CHDF) on vascular endothelial cell function in sepsis patients
por: Ikeda, K, et al.
Publicado: (2003)

A multicenter randomized controlled study of an extracorporeal cytokine hemoadsorption device in septic patients
por: Schädler, D, et al.
Publicado: (2013)

Clinical effects of polymyxin B immobilised fiber with direct hemoperfusion for the patients of severe sepsis or septic shock caused by intra-abdominal infections
por: Ikeda, T, et al.
Publicado: (2009)

Effects of endotoxin elimination therapy using polymyxin B immobilized fiber in patients with septic shock after surgical operation
por: Ikeda, T, et al.
Publicado: (1997)

Endotoxin adsorption method may affect serum procalcitonin
por: Ikeda, T, et al.
Publicado: (2008)

Endotoxin removal by hemoperfusion in septic shock
por: Adamik, B, et al.
Publicado: (2011)

Why measure endotoxin in septic shock patients?
por: Monti, G, et al.
Publicado: (2008)

Preclinical Pharmacokinetics of Complement C5a Receptor Antagonists PMX53 and PMX205 in Mice
por: Kumar, Vinod, et al.
Publicado: (2020)

Blood purification in sepsis and COVID-19: what´s new in cytokine and endotoxin hemoadsorption
por: Ruiz-Rodríguez, Juan Carlos, et al.
Publicado: (2022)

Usefulness of the endotoxin activity assay as a biomarker to assess severity in ICU patients
por: Noguchi, M, et al.
Publicado: (2014)

Efficacy of direct hemoperfusion using polymyxin B-immobilized fiber column (PMX-DHP) in rapidly progressive interstitial pneumonias: results of a historical control study and a review of previous studies
por: Ichiyasu, Hidenori, et al.
Publicado: (2017)

Pan-peritonitis due to intestinal perforation, and efficacy of direct hemoperfusion with polymyxin B immobilized fiber (PMX-20R)
por: Ikeda, T
Publicado: (1999)

Hemoadsorption by CytoSorb in septic patients: a case series
por: Kogelmann, Klaus, et al.
Publicado: (2017)

Experience with hemoadsorption (CytoSorb(®)) in the management of septic shock patients
por: Mehta, Yatin, et al.
Publicado: (2020)

Use of extracorporeal endotoxin elimination therapy for septic shock
por: Adamik, BA, et al.
Publicado: (2013)

The effect of endotoxin adsorber haemoperfusion on microcirculation in septic pigs
por: Yeh, Y-C, et al.
Publicado: (2015)

Rates of agreement of endotoxin, procalcitonin and lactate in septic and non-septic critically ill patients
por: Foster, D, et al.
Publicado: (2005)

Prevalence and clinical significance of early endotoxin activity in septic shock patients
por: Bottiroli, M, et al.
Publicado: (2015)

Hypercytokinemia and Pathogen–Host Interaction in COVID-19
por: Badawi, Alaa
Publicado: (2020)

Effects of steroid therapies to severe streptococcal pneumoniae that required mechanical ventilation
por: Nagura, T, et al.
Publicado: (2013)

Can urinary 8-OHdG be a good indicator of vasospasm occurrence following subarachnoid hemorrhage?
por: Ikeda, K, et al.
Publicado: (2012)

Background factors in patients receiving immunoglobulin administration and changes in sepsis markers
por: Ikeda, T, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_tiitt9gq98r99j1shf440v7lee